BioNJ Unveils "Time Off for Clinical Trials" Initiative

PR NewswireNov 20 23:00

HALO Vs. FOLD: Which Stock Should Value Investors Buy Now?

Zacks Nov 19 23:50

Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA

Seeking AlphaNov 17 22:18

Amicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

BenzingaNov 13 02:03

J.P. Morgan Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Announces Target Price $17

Futu NewsNov 13 01:32 · Ratings

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?

Simply Wall StNov 11 20:57